Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

1.

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID.

Lancet Respir Med. 2015 Apr 10. pii: S2213-2600(15)00106-X. doi: 10.1016/S2213-2600(15)00106-X. [Epub ahead of print]

PMID:
25878028
2.

Biomarkers and inhaled corticosteroid responsiveness in asthmatic patients.

Pavord ID, Hilvering B.

J Allergy Clin Immunol. 2015 Apr;135(4):884-5. doi: 10.1016/j.jaci.2015.01.031. No abstract available.

PMID:
25843601
3.

Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?

Gaillard EA, McNamara PS, Murray CS, Pavord ID, Shields MD.

Clin Exp Allergy. 2015 Mar 24. doi: 10.1111/cea.12535. [Epub ahead of print]

PMID:
25809678
4.

Asthma diagnosis: addressing the challenges.

Pavord ID, Bush A, Holgate S.

Lancet Respir Med. 2015 Mar 5. pii: S2213-2600(15)00056-9. doi: 10.1016/S2213-2600(15)00056-9. [Epub ahead of print] No abstract available.

PMID:
25753861
5.

What goes up must come down: biomarkers and novel biologicals in severe asthma.

Hilvering B, Pavord ID.

Clin Exp Allergy. 2015 Feb 1. doi: 10.1111/cea.12500. [Epub ahead of print]

PMID:
25640208
6.

IL-33-dependent Th2 response after rhinovirus infection in asthma: more information needed.

Hilvering B, Xue L, Pavord ID.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):237. doi: 10.1164/rccm.201411-2067LE. No abstract available.

PMID:
25590160
7.

Inhaled glucocorticoids and COPD exacerbations.

Brightling CE, Pavord ID, Bafadhel M.

N Engl J Med. 2015 Jan 1;372(1):93. doi: 10.1056/NEJMc1413308#SA3. No abstract available.

PMID:
25551538
8.

Temporal assessment of airway remodeling in severe asthma using quantitative computed tomography.

Gupta S, Hartley R, Singapuri A, Hargadon B, Monteiro W, Pavord ID, Sousa AR, Marshall RP, Subramanian D, Parr D, Entwisle JJ, Siddiqui S, Raj V, Brightling CE.

Am J Respir Crit Care Med. 2015 Jan 1;191(1):107-10. doi: 10.1164/rccm.201406-1128LE. No abstract available.

PMID:
25551349
9.

Glucocorticoids and mepolizumab in eosinophilic asthma.

Bel EH, Ortega HG, Pavord ID.

N Engl J Med. 2014 Dec 18;371(25):2434. doi: 10.1056/NEJMc1412892. No abstract available.

10.

The role of biomarkers in the management of airways disease.

Baines KJ, Pavord ID, Gibson PG.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1264-8. doi: 10.5588/ijtld.14.0226.

PMID:
25299856
11.

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.

Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 15;9:975-81. doi: 10.2147/COPD.S63568. eCollection 2014.

12.

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators.

N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8.

13.

Mepolizumab treatment in patients with severe eosinophilic asthma.

Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators.

N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8.

14.

A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response.

Morice AH, Jakes AD, Faruqi S, Birring SS, McGarvey L, Canning B, Smith JA, Parker SM, Chung KF, Lai K, Pavord ID, van den Berg J, Song WJ, Millqvist E, Farrell MJ, Mazzone SB, Dicpinigaitis P; Chronic Cough Registry.

Eur Respir J. 2014 Nov;44(5):1149-55. doi: 10.1183/09031936.00217813. Epub 2014 Sep 3.

PMID:
25186267
15.

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study.

Wilson E, McKeever T, Hargadon B, Hearson G, Anderson J, Hodgson D, Bailey H, Meakin G, Thomas M, Pavord ID, Harrison T, Shaw D.

Eur Respir J. 2014 Dec;44(6):1705-7. doi: 10.1183/09031936.00093614. Epub 2014 Aug 19. No abstract available.

PMID:
25142486
16.

Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease.

Ghebre MA, Bafadhel M, Desai D, Cohen SE, Newbold P, Rapley L, Woods J, Rugman P, Pavord ID, Newby C, Burton PR, May RD, Brightling CE.

J Allergy Clin Immunol. 2015 Jan;135(1):63-72. doi: 10.1016/j.jaci.2014.06.035. Epub 2014 Aug 13.

17.

Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.

Barker BL, Haldar K, Patel H, Pavord ID, Barer MR, Brightling CE, Bafadhel M.

Chest. 2015 Jan;147(1):46-55. doi: 10.1378/chest.14-0764.

18.

The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use.

Barnes PJ, Casale TB, Dahl R, Pavord ID, Wechsler ME.

Allergy. 2014 Sep;69(9):1119-40. doi: 10.1111/all.12415. Epub 2014 Jul 15. Review.

PMID:
25039248
19.

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.

Bafadhel M, Davies L, Calverley PM, Aaron SD, Brightling CE, Pavord ID.

Eur Respir J. 2014 Sep;44(3):789-91. doi: 10.1183/09031936.00062614. Epub 2014 Jun 12. No abstract available.

PMID:
24925917
20.

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.

Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID.

Int J Chron Obstruct Pulmon Dis. 2014 Feb 7;9:179-86. doi: 10.2147/COPD.S55419. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk